Bio-Techne
TECH
#1485
Rank
NZ$21.13 B
Marketcap
$133.04
Share price
1.09%
Change (1 day)
22.26%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Earnings for Bio-Techne (TECH)

Earnings in 2024 (TTM): NZ$0.30 Billion

According to Bio-Techne's latest financial reports the company's current earnings are NZ$1.17 Billion. In 2023 the company made an earning of NZ$0.48 Billion a decrease over its 2022 earnings that were of NZ$0.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bio-Techne from 1991 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.30 B-35.94%
2023 NZ$0.48 B-19.25%
2022 NZ$0.59 B50.77%
2021 NZ$0.39 B-1.3%
2020 NZ$0.40 B-15.46%
2019 NZ$0.47 B82.56%
2018 NZ$0.25 B11.13%
2017 NZ$0.23 B1.19%
2016 NZ$0.23 B-12.64%
2015 NZ$0.26 B-9.33%
2014 NZ$0.29 B2.19%
2013 NZ$0.28 B-1.7%
2012 NZ$0.28 B-3.5%
2011 NZ$0.30 B6.2%
2010 NZ$0.28 B-0.59%
2009 NZ$0.28 B2.78%
2008 NZ$0.27 B14.95%
2007 NZ$0.24 B15.14%
2006 NZ$0.20 B11.66%
2005 NZ$0.18 B17.05%
2004 NZ$0.15 B18.06%
2003 NZ$0.13 B26.06%
2002 NZ$0.10 B22.66%
2001 NZ$87.62 M9.92%
2000 NZ$79.71 M43.92%
1999 NZ$55.39 M31.99%
1998 NZ$41.96 M29.61%
1997 NZ$32.37 M31.62%
1996 NZ$24.6 M34.65%
1995 NZ$18.26 M16.09%
1994 NZ$15.73 M29.85%
1993 NZ$12.11 M6.35%
1992 NZ$11.39 M152%
1991 NZ$4.52 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.36 B 3,510.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.82 Billion-630.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.62 B 959.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.38 B 2,056.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.28 B-15.85%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$14.99 B 4,277.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$13.05 Million-103.81%๐Ÿ‡บ๐Ÿ‡ธ USA